Abstract
Until recently, most transplant units required that a negative crossmatch using all available sera was an essential criterion which would ensure the best use of a donor kidney. This policy was accepted without clinical trial until 1982 when it was suggested that a donor kidney will function successfully in the majority of recipients with a negative crossmatch using current sera and a positive crossmatch with one or more non-current sera, i. e., sera taken 3 or more months prior to the time of the transplant. In the 14 reported series addressing this question, the average 1-year graft survival ranges between 53% and 100% in these highly sensitized patients who receive a primary graft, and between 0% and 100% in those who receive a secondary graft. Controversy does exist as to whether a positive crossmatch in non-current sera is an additional risk factor, i.e., that it decreases graft survival significantly when compared with a similar group of highly sensitized patients who were transplanted with a negative crossmatch on all available pre-transplant sera. Of the published studies on this subject, the majority, but not all, find that there is no difference between controls and positive crossmatch patients who receive a primary graft, but those that receive a secondary graft may be at increased risk. The reasons for the different results from these studies may be related to differences in the many variables which influence graft outcome between various study groups.
Similar content being viewed by others
References
Kissmeyer-Neilson F, Olsen S, Peterson VP, Fjeldborg O (1966) Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet I:662–665
Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 288:735–739
Cardella CJ, Falk JA, Nicholson MJ, Harding M, Cook GT (1982) Successful renal transplantation in patients with T-cell reactivity to donor. Lancet II:1240–1243
Cardella CJ, Falk JA, Halloran PF, Robinette MA, Arbus GA, Bear RA (1985) Risk factors in renal transplant recipients with a positive crossmatch on noncurrent sera. Transplant Proc 17:2446–2448
Sanfilippo F, Vaughn WK, Spees EK, Bollinger RR (1984) Cadaver renal transplantation ignoring peak-reactive sera in patients with markedly decreasing pretransplant sensitization. Transplantation 38:119–124
Matas AJ, Nehlsen-Cannarella S, Tellis VA, Kuemmel P, Soberman R, Veith FJ (1984) Successful kidney transplantation with current-sera-negative/historical-sera-positive T cell crossmatch. Transplantation 37:111–112
Matas AJ, Tellis VA, Glicklich D, Soberman R, Veith FJ (1988) Transplantation with a past positive crossmatch and cyclosporine immunosuppression: a 5-year experience. Clin Transplant 2:336–340
Goeken NE and the Clinical Affairs Committee (1985) Outcome of renal tansplantation following a positive cross-match with historical sera: the ASHI survey. Hum Immunol 14:77–85
Rosenthal JT, Rabin B, Taylor RJ, Griffith M, Carpenter B, Hakala TR (1985) Positive T cell crossmatch with stored recipient sera in cadaveric renal transplantation. Transplantation 39:310–311
Norman DJ, Barry JM, Wetzsteon PJ (1985) Successful cadaver kidney transplantation in patients highly sensitized by blood transfusions. Transplantation 39:253–255
Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Kahan BD (1985) Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches. Transplantation 40:615–619
Baquero A, Om A, McAlack R, Raja R, Bannett AD (1987) Successful cadaveric and living related donor renal transplantation in patients with historical positive and pretransplant negative crossmatch. Transplant Proc 2946–2948
Hodge E, Novick A, Lewis R, Steinmuller D, Streem S, Cunningham R, Braun W, Zachary A, Protiva D (1987) Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches. Transplant Proc: 789–791
Bollinger RR, Baughn W, Sanfilippo F, Lucas B, Lefor W, Peters T, Bias W (1987) Results of the South-Eastern Organ Procurement Foundation strategy for transplanting sensitized patients. Transplant Proc: 1964–1966
Turka LA, Goguen JE, Gagne JE, Milford EL (1989) Presensitization and the renal allograft recipient. Transplantation 47:234–240
Chapman JR, Taylor CJ, Ting A, Morris PJ (1986) Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Transplantation 42:608–613
Reed E, Hardy M, Benvenisty A, Lattes C, Brensilver J, McCabe R, Reemstma K, King DW, Suciu-Foca N (1987) Effect of Antiidiotypic antibodies to HLA on graft survival in renal allograft recipients. N Engl J Med 316:1450–1455
Falk JA, Cardella CJ, Halloran PF, Bear RA, Arbus GS (1987) Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current sera. Transplant Proc 19:720–721
Ayoub GM, Terasaki PI, Tnai RJ (1983) Improvements in detection of sensitization. Transplant Proc 15:1202–1207
Noreen HJ, der Hagen E ver, Bach FH, Najarian JA, Fryd DS (1989) Renal allograft survival in CSA-treated patients with positive donorspecific B cell crossmatches. Transplant Proc 21:691–692
Cardella CJ, Falk JA (1983) Graft outcome in patients with antibodies reactive with donor T and B cells. Transplant Proc 15: 1142–1144
Phelan DL, Rodey GE, Flye MW, Hanto DW, Anderson CB, Mohanakumar T (1989) Positive B cell crossmatches: specificity of antibody and graft outcome. Transplant Proc 21:687–688
Delmonico FL, Fuller A, Cosimi B, Tolkoff-Rubin N, Russell PS, Rodey GE, Fuller TC (1983) New approaches to donor crossmatching and successful transplantation of highly sensitized patients. Transplantation 36:629–633
Talbot D, Givan AL, Shenton BK, Stratton A, Proud G, Taylor RMR (1989) The relevance of a more sensitive crossmatch assay to renal transplantation. Transplant Proc: 552–555
Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJC, Garovoy M, Salvatierra O (1989) Successful management of the highly sensitized renal allograft recipient. Transplant Proc 21:751–753
Taube D, Palmer A, Welsh K, Bewick M, Snowden S, Thick M (1989) Removal of anti-HLA antibodies prior to transplantation: an effective and successful strategy for highly sensitized renal allograft recipients. Transplant Proc 21:694–695
Casadei D, Carmen Rial M del, Zarazaga CN, Vila N (1989) Historical positive cross-matches in renal transplantation with living donors: an analysis of thirteen cases. Transplant Proc 21:745
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cardella, C.J. The use of the kidney with an historical positive, and current negative crossmatch. Pediatr Nephrol 5, 126–129 (1991). https://doi.org/10.1007/BF00852869
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00852869